INCYTE CORP — Director's Dealing 2023

Aug 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2023-08-01

Reporting Person: Stein Steven H (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-01	Common Stock	S	21511	$63.28	Disposed	97583	Direct

Footnotes

F1: This includes an aggregate of 87,659 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.